Drug | PIM, n (%) | |||||
STOPP | START | Usual care | Total | |||
Admission | Discharge | Admission | Discharge | Admission | ||
Acenocoumarol | 2 (4.4 %) | 0 | 4 (4.2%) | 2 (2.3%) | 0 | 8 (2.7%) |
Acetylsalicylic | 3 (6.5%) | 0 | 21 (21.9%) | 20(23.3%) | 0 | 44 (15.1%) |
Amlodipine | 4 (8.7%) | 3 (10.3%) | 0 | 0 | 0 | 7 (2.4%) |
Calcium+vitamin D | 0 | 0 | 14 (14.6%) | 9 (10.5%) | 0 | 23 (7.9%) |
Enalapril | 0 | 0 | 18 (18.8%) | 15 (17.4%) | 0 | 33 (11.3%) |
Ipratropium | 4 (8.7%) | 1 (3.5%) | 0 | 0 | 0 | 5 (1.7%) |
Levofloxacin | 0 | 0 | 0 | 0 | 5 (14.7%) | 5 (1.7%) |
Lorazepam | 1 (2.2%) | 5 (17.2%) | 0 | 0 | 0 | 6 (2.1%) |
Metformin | 0 | 0 | 11 (11.5%) | 11 (12.8%) | 0 | 22 (7.6%) |
Omeprazole | 0 | 0 | 0 | 0 | 7 (20.6%) | 7 (2.4%) |
Quetiapine | 2 (4.4%) | 5 (17.2%) | 0 | 0 | 0 | 7 (2.4%) |
Simvastatin | 0 | 0 | 27 (28.1%) | 26 (30.2%) | 1 (2.9%) | 54 (18.6%) |
Tamsulosin | 9 (19.6%) | 8 (27.6%) | 0 | 0 | 0 | 17 (5.8%) |
Others | 21 (45.5%) | 7 (24.2%) | 1 (0.9%) | 3 (3.5%) | 21 (61.8%) | 53 (18.2%) |